Shoulder Pain, Core Endurance, and Scapular Control in Adolescent Volleyball Players (NCT07720050) | Clinical Trial Compass
CompletedNot Applicable
Shoulder Pain, Core Endurance, and Scapular Control in Adolescent Volleyball Players
Turkey (Türkiye)60 participantsStarted 2026-03-15
Plain-language summary
Shoulder pain is one of the most common musculoskeletal problems in adolescent volleyball players because of repetitive overhead activities such as serving and spiking. Although impaired scapular control and reduced core endurance have been suggested as potential contributors to shoulder pain, their combined relationship has not been sufficiently investigated in young volleyball athletes.
This observational cross-sectional study aims to examine the relationship between shoulder pain, core endurance, and scapular control in licensed adolescent volleyball players aged 14 to 18 years. Participants with and without shoulder pain will undergo standardized assessments, including the Visual Analog Scale (VAS) for pain intensity, the Scapular Dyskinesis Test for scapular control, and the McGill Core Endurance Test Battery for trunk muscle endurance. The findings are expected to improve the understanding of factors associated with shoulder pain and contribute to the development of injury prevention and rehabilitation strategies for adolescent volleyball players.
Who can participate
Age range
14 Years – 18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female licensed volleyball players aged 14 to 18 years.
* Participation in regular volleyball training at least three times per week.
* Dominant upper extremity identified.
* Ability to understand the study procedures and provide informed assent.
* Written informed consent provided by a parent or legal guardian for participants younger than 18 years.
Exclusion Criteria:
* Shoulder surgery within the previous 6 months.
* Acute upper extremity or spinal injury.
* History of fracture affecting the upper extremity or spine.
* Neurological disorders affecting upper extremity function.
* Systemic rheumatologic disease.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.